300715-96-2 Usage
General Description
1,3,4,5-Tetrahydro-pyrido[4,3-b]indole-2,8-dicarboxylic acid 2-tert-butyl ester is a chemical compound that belongs to the class of pyridoindole derivatives. It is a crystalline solid with a molecular formula of C20H25NO4 and a molecular weight of 347.42 g/mol. 1,3,4,5-TETRAHYDRO-PYRIDO[4,3-B]INDOLE-2,8-DICARBOXYLIC ACID 2-TERT-BUTYL ESTER is often used as a building block in the synthesis of various organic compounds and pharmaceuticals. It has been studied for its potential biological activities, including as an anti-cancer agent and an inhibitor of enzymes involved in inflammation and oxidative stress. Overall, 1,3,4,5-tetrahydro-pyrido[4,3-b]indole-2,8-dicarboxylic acid 2-tert-butyl ester is a versatile chemical with potential applications in medicinal and synthetic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 300715-96-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,0,7,1 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 300715-96:
(8*3)+(7*0)+(6*0)+(5*7)+(4*1)+(3*5)+(2*9)+(1*6)=102
102 % 10 = 2
So 300715-96-2 is a valid CAS Registry Number.
300715-96-2Relevant articles and documents
Targeting low-druggability bromodomains: Fragment based screening and inhibitor design against the BAZ2B bromodomain
Ferguson, Fleur M.,Fedorov, Oleg,Chaikuad, Apirat,Philpott, Martin,Muniz, Joao R. C.,Felletar, Ildiko,Von Delft, Frank,Heightman, Tom,Knapp, Stefan,Abell, Chris,Ciulli, Alessio
, p. 10183 - 10187 (2014/01/17)
Bromodomains are epigenetic reader domains that have recently become popular targets. In contrast to BET bromodomains, which have proven druggable, bromodomains from other regions of the phylogenetic tree have shallower pockets. We describe successful tar
NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1’ RECEPTOR LIGANDS
-
Page/Page column 24; 30; 31, (2010/11/24)
Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein R1, R2 and R3 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
